2.8 Sprzedawca nie ponosi odpowiedzialnoci za skutki uycia Produktw niezgodnie z ich przeznaczeniem, w szczeglnoci za skutki spoycia, podania, aplikacji, odsprzeday lub wykorzystania Produktw poza warunkami badawczymi
We can't stress this enough: store your vials at the back of the main compartment, never in the door
In a 2018 guidance, FDA explained that it would consider a compounded drug to be essentially a copy of a commercially available drug if it has (i) the same API, (ii) the same or similar dosage, and (iii) the same route of administration, unless a prescriber determines that there is a change, made for an identified individual patient, which produces, for that patient, a significant difference from the commercially available drug product. The guidance also explains that, if a change is made for an identified patient, the prescriber should document the determination on the prescription, and the notations should be specific
Primarily, it improves glycemic control, but it also assists with weight loss
Audit your copy this week, replace brand comparisons with accurate descriptions, and treat certification as the compliance layer it is
It should not be combined with other semaglutide or GLP-1 products